RLYB Stock Analysis: Buy, Sell, or Hold?
RLYB - Rallybio Corporation Common Stock
$15.82
-0.13 (-0.78%)
▼
5d:
+0.67%
30d:
-2.56%
90d:
+88.27%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When RLYB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RLYB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RLYB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RLYB is currently trading at $15.81, which is considered fair relative to its 30-day fair value range of $15.22 to $16.32.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $14.21, while resistance sits at $17.57.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $8.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $14.21, while resistance sits at $17.57.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $8.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$15.22 -
$16.32
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 49.4% above Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$15.22 -
$16.32
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$14.21
Resistance Level
$17.57
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.39
Wall Street Target
$8.00
(-49.4%)
Share & Embed Analysis
Last updated: July 02, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLYB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan I Lieber
SELL
789 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$89 | 64 BUY |
